~~<i id='16994BB677'><strike id='16994BB677'><tt id='16994BB677'><pre id='16994BB677'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：focus 2025-09-27 23:32:57 - browse：3225

Monica Bertagnolli -- health policy coverage from STAT — NIH Director Monica Bertagnolli Kevin Dietsch/Getty Images

WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally funded research — and now, in a major recent move, said he’ll trigger government “march-in” on patents for drugs that run afoul of that goal.

“It’s a simple principle. You shouldn’t pay the highest price in the world for drugs that your tax dollars have already helped create,” Biden said last month as he touted the move at the National Institutes of Health.

But the new NIH director, locked in the center of this debate, isn’t taking any big steps yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Trump's false claims about Georgia's 2020 election long debunked

hotspot

leisure time

focus

hotspot

3:16UkrainiansoldiersfireamortartowardsRussianpositionsatthefrontline,nearBakhmut,Donetskregion,Ukra

WSS

CDC advisers recommend seasonal use of Pfizer RSV shot

Listen: Racing for gene therapy & a pioneering approval

Emergency workers more likely to restrain Black patients: study

Beware the threat of staffing cuts at the CDC

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Clinical trials must include more disabled people

focus

fashion

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

ProMED sees offers of support, but its future remains unclear

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

New definition of a human embryo proposed amid rapid advances

At least 13 dead in Texas as scorching temps continue

ActiGraph execs on goal of drug approvals with digital endpoints

Guidelines to prevent youth baseball injuries need more muscle

Intarcia’s device

Cancer drug shortages should be causing more outrage

Ukraine taking heavy casualties 10 weeks into its counteroffensive

leisure time

Lasker Awards 2023: Winners in biomedical research

FDA approves first treatment for ultra

Congress must give Medicare recipients genetic counseling access

Trump's false claims about Georgia's 2020 election long debunked

Biotech lab space demand falls sharply

An interview with Robert F. Kennedy Jr. on vaccines

focus

focus

hotspot

hotspot